Blake Byers

Investment Partner , Angel

Overview

Gender
male
Investor Type
Investment Partner,Angel
Investor Stage
Seed

Blake Byers began doing biomedical research as a high school student at Stanford in 2002, and has worked in seven laboratories over the last nine years. Outside of lab, he has worked as a marketer at Electronic Arts, a pharmaceutical equity research analyst at Morgan Stanley, and an angel investor. Blake’s research has spanned antibiotic mechanisms of action, endothelial cell binding, bioimpediance device design, mesendoderm stem cell isolation, Parkinson’s disease modeling, and fMRI imaging of allogeneic brain grafts — resulting in multiple publications and two first author papers (Cell Stem Cell, 2011 and PLoS One, 2011).

Blake received a Bachelor of Science in biomedical engineering and Bachelor of Science in economics from Duke University and holds a Master of Science and Ph.D. in bioengineering from Stanford University.

Personal Investments

Number of Investments
2
Blake Byers has made 2 investments. Their most recent investment was on Nov 2, 2022, when Arta Finance raised $90M.
Date Company Name Round Money Raised Industry
Nov 2, 2022 Arta Finance Series A $90M Finance Detail
Jul 30, 2021 Neuralink Series C $205M Hardware Detail

Jobs

Number of Current Jobs
3
Blake Byers has 3 current jobs including Board Observer at Arcus Biosciences , Board Chairman at PACT Pharma and President at PACT Pharma .
Organization Name Title At Company Start Date End Date
Arcus Biosciences Board Observer Jan 1, 2016 Detail
PACT Pharma Board Chairman Jan 1, 2016 Detail
PACT Pharma President Detail